|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lv Y, Zhang J and Qiao L: Quality of life
in patients with esophageal cancer receiving definitive
chemoradiotherapy or esophagectomy. Mol Clin Oncol. 2:870–874.
2014.PubMed/NCBI
|
|
4
|
Li SQ, Li F, Xiao Y, Wang CM, Tuo L, Hu J,
Yang XB, Wang JS, Shi WH, Li X, et al: Comparison of long non
coding RNAs, microRNAs and messenger RNAs involved in initiation
and progression of esophageal squamous cell carcinoma. Mol Med Rep.
10:652–662. 2014.PubMed/NCBI
|
|
5
|
Lu J, Xue L, Jin M and Lyu N: Expression
profiling of metastasis-related microRNAs in early esophageal
squamous cell carcinoma. Zhonghua Bing Li Xue Za Zhi. 43:313–317.
2014.In Chinese. PubMed/NCBI
|
|
6
|
Pan F, Yao J, Chen Y, Zhou C, Geng P, Mao
H and Fang X: A novel long non-coding RNA FOXCUT and mRNA FOXC1
pair promote progression and predict poor prognosis in esophageal
squamous cell carcinoma. Int J Clin Exp Pathol. 7:2838–2849.
2014.PubMed/NCBI
|
|
7
|
Ge H, Lu Y, Chen Y, Zheng X, Wang W and Yu
J: ERCC1 expression and tumor regression predict survival in
esophageal squamous cell carcinoma patients receiving combined
trimo-dality therapy. Pathol Res Pract. 210:656–661. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caporali A and Emanueli C: MicroRNA
regulation in angio-genesis. Vascul Pharmacol. 55:79–86. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banaudha KK and Verma M: The role of
microRNAs in the management of liver cancer. Methods Mol Biol.
863:241–251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gallardo E, Navarro A, Viñolas N, Marrades
RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez
J, et al: miR-34a as a prognostic marker of relapse in surgically
resected non-small-cell lung cancer. Carcinogenesis. 30:1903–1909.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Mo R, Yin B, Zhou L, Liu Y and
Fan J: Tumor suppressor microRNA-34a inhibits cell proliferation by
targeting Notch1 in renal cell carcinoma. Oncol Lett. 7:1689–1694.
2014.PubMed/NCBI
|
|
14
|
Peng Y, Guo JJ, Liu YM and Wu XL:
MicroRNA-34a inhibits the growth, invasion and metastasis of
gastric cancer by targeting PDGFR and MET expression. Biosci Rep.
34:e001122014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corcoran C, Rani S and O’Driscoll L:
miR-34a is an intracellular and exosomal predictive biomarker for
response to docetaxel with clinical relevance to prostate cancer
progression. Prostate. 74:1320–1334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daige CL, Wiggins JF, Priddy L,
Nelligan-Davis T, Zhao J and Brown D: Systemic delivery of a miR34a
mimic as a potential therapeutic for liver cancer. Mol Cancer Ther.
13:2352–2360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Zhang S, Xie L, Liu P, Xie F, Wu
J, Cao J and Ding WQ: Overexpression of DNA polymerase iota (Polι)
in esophageal squamous cell carcinoma. Cancer Sci. 103:1574–1579.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Jiang X, Cao L, Dai K, Zhang S, Ge
X, Zhou X and Lu X: Expression of YY1 correlates with progression
and metastasis in esophageal squamous cell carcinomas. Onco Targets
Ther. 7:1753–1759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maire G, Martin JW, Yoshimoto M,
Chilton-MacNeill S, Zielenska M and Squire JA: Analysis of
miRNA-gene expression-genomic profiles reveals complex mechanisms
of microRNA deregulation in osteosarcoma. Cancer Genet.
204:138–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siemens H, Neumann J, Jackstadt R,
Mansmann U, Horst D, Kirchner T and Hermeking H: Detection of
miR-34a promoter methylation in combination with elevated
expression of c-Met and β-catenin predicts distant metastasis of
colon cancer. Clin Cancer Res. 19:710–720. 2013. View Article : Google Scholar
|
|
22
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guessous F, Zhang Y, Kofman A, Catania A,
Li Y, Schiff D, Purow B and Abounader R: microRNA-34a is tumor
suppressive in brain tumors and glioma stem cells. Cell Cycle.
9:1031–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silber J, Jacobsen A, Ozawa T, Harinath G,
Pedraza A, Sander C, Holland EC and Huse JT: miR-34a repression in
proneural malignant gliomas upregulates expression of its target
PDGFRA and promotes tumorigenesis. PLoS One. 7:e338442012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stetler-Stevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O’Higgins N: Metalloproteinases: role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar
|
|
28
|
Leeman MF, Curran S and Murray GI: New
insights into the roles of matrix metalloproteinases in colorectal
cancer development and progression. J Pathol. 201:528–534. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeong HM, Lee SH, Yum J, Yeo CY and Lee
KY: Smurf2 regulates the degradation of YY1. Biochim Biophys Acta.
1843:2005–2011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Allouche A, Nolens G, Tancredi A,
Delacroix L, Mardaga J, Fridman V, Winkler R, Boniver J, Delvenne P
and Begon DY: The combined immunodetection of AP-2alpha and YY1
transcription factors is associated with ERBB2 gene overexpression
in primary breast tumors. Breast Cancer Res. 10:R92008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zaravinos A and Spandidos DA: Yin yang 1
expression in human tumors. Cell Cycle. 9:512–522. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kashyap V and Bonavida B: Role of YY1 in
the pathogenesis of prostate cancer and correlation with
bioinformatic data sets of gene expression. Genes Cancer. 5:71–83.
2014.PubMed/NCBI
|
|
33
|
Huerta-Yepez S, Liu H, Baritaki S, Del
Lourdes Cebrera-Muñoz M, Rivera-Pazos C, Maldonado-Valenzuela A,
Valencia-Hipolito A, Vega MI, Chen H, Berenson JR, et al:
Overexpression of Yin Yang 1 in bone marrow-derived human multiple
myeloma and its clinical significance. Int J Oncol. 45:1184–1192.
2014.PubMed/NCBI
|
|
34
|
Notarbartolo M, Giannitrapani L, Vivona N,
Poma P, Labbozzetta M, Florena AM, Porcasi R, Muggeo VM, Sandonato
L, Cervello M, et al: Frequent alteration of the Yin Yang 1/Raf-1
kinase inhibitory protein ratio in hepatocellular carcinoma. OMICS.
15:267–272. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luo J, Zhou X, Ge X, Liu P, Cao J, Lu X,
Ling Y and Zhang S: Upregulation of Ying Yang 1 (YY1) suppresses
esophageal squamous cell carcinoma development through heme
oxygenase-1. Cancer Sci. 104:1544–1551. 2013. View Article : Google Scholar : PubMed/NCBI
|
